Summary:
- The article discusses a study that investigated the use of a novel drug delivery system to improve the effectiveness of gene therapy for Duchenne muscular dystrophy (DMD).
- The study found that the drug delivery system, which uses a modified virus to transport the gene therapy, was able to effectively target and deliver the treatment to the muscles of mice with DMD.
- The results suggest that this approach could potentially lead to more effective gene therapy treatments for DMD and other genetic muscle disorders.